Literature DB >> 20472668

Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways.

Francisney P Nascimento1, Sonia M Figueredo, Rodrigo Marcon, Daniel F Martins, Sérgio J Macedo, Denise A N Lima, Rúbia C Almeida, Rosana M Ostroski, Ana Lúcia S Rodrigues, Adair Roberto Soares Santos.   

Abstract

Inosine, an endogenous purine, is the first metabolite of adenosine in a reaction catalyzed by adenosine deaminase. This study aimed to investigate the antinociceptive effects of inosine against several models of pain in mice and rats. In mice, inosine given by systemic or central routes inhibited acetic acid-induced nociception. Furthermore, inosine also decreased the late phase of formalin-induced licking and the nociception induced by glutamate. Inosine produced inhibition (for up to 4 h) of mechanical allodynia induced by complete Freund's adjuvant (CFA) injected into the mouse's paw. Given chronically for 21 days, inosine reversed the mechanical allodynia caused by CFA. Moreover, inosine also reduced the thermal (cold stimuli) and mechanical allodynia caused by partial sciatic nerve ligation (PSNL) for 4 h; when inosine was chronically administered, it decreased the mechanical allodynia induced by PSNL for 22 days. Antinociception caused by inosine in the acetic acid test was attenuated by treatment of mice with 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; a selective adenosine A(1) receptor antagonist), 8-phenyltheophylline (8-PT; a nonselective adenosine A(1) receptor antagonist), and 4-{2- [7-amino-2-(2-furyl)[1,2,4]triazolo-[2,3-a][1,3,5]triazin-5-yl- amino]ethyl}phenol (ZM241385; a selective adenosine A(2A) receptor antagonist). In rats, inosine inhibited the mechanical and heat hyperalgesia induced by bradykinin and phorbol 12-myristate 13-acetate, without affecting similar responses caused by prostaglandin E(2) or forskolin. These results indicate that inosine induces antinociceptive, antiallodynic, and antihyperalgesic effects in rodents. The precise mechanisms through which inosine produces antinociception are currently under investigation, but involvement of adenosine A(1) and A(2A) receptors and blockade of the protein kinase C pathway seem to largely account for inosine's antinociceptive effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472668     DOI: 10.1124/jpet.110.166058

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects.

Authors:  Francisney Pinto Nascimento; Sérgio José Macedo-Júnior; Fabrício Alano Pamplona; Murilo Luiz-Cerutti; Marina Machado Córdova; Leandra Constantino; Carla Inês Tasca; Rafael Cypriano Dutra; João B Calixto; Allison Reid; Jana Sawynok; Adair Roberto Soares Santos
Journal:  Mol Neurobiol       Date:  2014-07-27       Impact factor: 5.590

2.  Light-Emitting Diode Phototherapy Reduces Nocifensive Behavior Induced by Thermal and Chemical Noxious Stimuli in Mice: Evidence for the Involvement of Capsaicin-Sensitive Central Afferent Fibers.

Authors:  Glauce Regina Pigatto; Igor Santos Coelho; Rosane Schenkel Aquino; Liliane Freitas Bauermann; Adair Roberto Soares Santos
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

3.  Role of pertussis toxin-sensitive G-protein, K+ channels, and voltage-gated Ca2+ channels in the antinociceptive effect of inosine.

Authors:  Sérgio José Macedo-Junior; Francisney Pinto Nascimento; Murilo Luiz-Cerutti; Adair Roberto Soares Santos
Journal:  Purinergic Signal       Date:  2012-07-18       Impact factor: 3.765

4.  The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.

Authors:  Ajith A Welihinda; Manmeet Kaur; Kelly Greene; Yongjiao Zhai; Edward P Amento
Journal:  Cell Signal       Date:  2016-02-19       Impact factor: 4.315

5.  Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Tanara V Peres; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  J Neural Transm (Vienna)       Date:  2017-07-10       Impact factor: 3.575

6.  Signaling pathways underlying the antidepressant-like effect of inosine in mice.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  Purinergic Signal       Date:  2016-12-13       Impact factor: 3.765

7.  The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.

Authors:  Manuella P Kaster; Josiane Budni; Marta Gazal; Mauricio P Cunha; Adair R S Santos; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2013-04-25       Impact factor: 3.765

8.  Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.

Authors:  Stella Célio Junqueira; Igor Dos Santos Coelho; Vicente Lieberknecht; Mauricio Peña Cunha; João B Calixto; Ana Lúcia S Rodrigues; Adair Roberto Soares Santos; Rafael Cypriano Dutra
Journal:  Mol Neurobiol       Date:  2016-04-30       Impact factor: 5.590

9.  Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A2A and A 3 receptors.

Authors:  Fernanda da Rocha Lapa; Ana Paula Ligeiro de Oliveira; Beatriz Golega Accetturi; Isabelli de Oliveira Martins; Helory Vanni Domingos; Daniela de Almeida Cabrini; Wothan Tavares de Lima; Adair Roberto Soares Santos
Journal:  Purinergic Signal       Date:  2013-01-26       Impact factor: 3.765

10.  Central adenosine A1 receptors inhibit cough via suppression of excitatory glutamatergic and tachykininergic neurotransmission.

Authors:  Ahmed Z El-Hashim; Seena Mathews; Fajer Al-Shamlan
Journal:  Br J Pharmacol       Date:  2018-06-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.